Skip to main content

Table 3 The predictors of PM in HCC patients

From: Preoperative PDW levels predict pulmonary metastasis in patients with hepatocellular carcinoma

Variables

Univariable

Multivariable

sHR (95% CI)

P-value

sHR (95% CI)

P-value

Development set

ā€ƒSex (male vs female)

0.405(0.164ā€“0.997)

0.049

0.443(0.170ā€“1.153)

0.095

ā€ƒVascular invasion (Yes vs No)

5.360(2.200ā€“13.100)

ā€‰<ā€‰0.001

2.610(0.898ā€“7.596)

0.078

ā€ƒTumor number (Multiple vs Single)

0.712(0.209ā€“2.430)

0.590

Ā Ā 

ā€ƒTumor differentiation (Poor vs Moderate/well)

1.310(0.498ā€“3.450)

0.580

Ā Ā 

ā€ƒCapsule (Incomplete vs Complete)

3.110(1.230ā€“7.850)

0.017

1.490(0.534ā€“4.181)

0.440

ā€ƒTumor size (cm)

1.330(1.200ā€“1.460)

ā€‰<ā€‰0.001

1.240(1.045ā€“1.481)

0.014

ā€ƒAFP (ng/mL)

1.000(1.000ā€“1.000)

0.090

Ā Ā 

ā€ƒPDW (%)

0.798(0.706ā€“0.901)

ā€‰<ā€‰0.001

0.850(0.736ā€“0.983)

0.028

Validation set

ā€ƒCirrhosis (Yes vs No)

0.089(0.011ā€“0.703)

0.022

0.376(0.028ā€“4.970)

0.460

ā€ƒChild Pugh score (B vs A)

6.270 (1.970ā€“19.900)

0.001

2.587(0.378ā€“17.682)

0.330

ā€ƒTumor size (cm)

1.530(1.350ā€“1.730)

ā€‰<ā€‰0.001

1.940(1.291ā€“2.915)

0.001

ā€ƒMELD score

0.944(0.686ā€“1.300)

0.720

Ā Ā 

ā€ƒPALBI

0.400(0.146ā€“1.100)

0.070

Ā Ā 

ā€ƒAFP (ng/mL)

1.000(1.000ā€“1.000)

0.630

Ā Ā 

ā€ƒHaemoglobin (g/L)

0.972(0.961ā€“0.983)

ā€‰<ā€‰0.001

1.046(0.988ā€“1.107)

0.120

ā€ƒPlatelet count (Ɨā€‰109/L)

1.010(1.000ā€“1.010)

0.016

1.001(0.990ā€“1.011)

0.920

ā€ƒPDW (%)

0.764(0.645ā€“0.904)

0.001

0.523(0.304ā€“0.898)

0.019

  1. sHR Subdistribution hazard ratio, CI Confidence interval Abbreviations: see to Table 1